DIN 02369613 — BANZEL 100 MG
BANZEL is a tablet of Rufinamide marketed by EISAI LIMITED. The full Rufinamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02369613
- Brand name
- BANZEL
- Active ingredient
- Rufinamide
- Strength
- 100 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- EISAI LIMITED
- Health Canada status
- MARKETED
- Drug class
- Antiepileptic (triazole derivative)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Rufinamide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02545985 | AURO-RUFINAMIDE | 200 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02545993 | AURO-RUFINAMIDE | 400 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02369621 | BANZEL | 200 MG | TABLET | EISAI LIMITED | MARKETED |
| 02369648 | BANZEL | 400 MG | TABLET | EISAI LIMITED | MARKETED |